LEE ADKINS

• Dedicated Pharmaceutical Research Management professional with:
• A direct, goal-oriented, transparent and supportive management style
• Cooperative, relationship-centered communication style
• 25+ years of combined, cross-functional, industry experience in advancing roles with increased leadership and oversight responsibilities; including
• Full-scope Phase I – IV Clinical Monitoring, Project and Program Management experience
• Oversight experience of study operations, timelines and budgets ranging from $450K to $24M
• 14+ years of direct Early Phase Oncology experience
• 3+ years as Project Director/Program Lead, dedicated to EPO Biotech Client Management
• 3+ years of Line Management experience, under direct and matrix models; and
• 6+ years in Clinical Monitoring and Clinical Team Lead roles.

Experienced with strategic planning, project management, and stakeholder communication. Utilizes these skills to enhance operational efficiency and drive team success. Track record of effective leadership in high-stakes environments.

Results-driven professional with extensive experience in leadership and strategic oversight. Adept at driving organizational success through effective team collaboration and dynamic problem-solving. Recognized for adaptability and keen focus on achieving objectives.

Qualified [Desired Position] with proven background in strategic planning and project management. Successfully led cross-functional teams to deliver high-impact initiatives. Demonstrated excellence in stakeholder communication and operational efficiency.

Professional leader with extensive experience in driving strategic initiatives and fostering effective team collaboration. Strong background in project management, budget oversight, and stakeholder engagement, ensuring organizational goals are met efficiently. Known for adaptability, reliability, and focus on achieving impactful results. Skilled in leveraging data-driven insights, optimizing processes, and mentoring teams to excel in dynamic environments.

Highly organized and self-motivated professional experienced in project management, team development and process improvement. Skilled in developing and implementing strategies to increase efficiency and performance. Passionate about driving business growth and creating positive work environment.

Encouraging manager and analytical problem-solver with talents for team building, leading and motivating, as well as excellent customer relations aptitude and relationship-building skills. Proficient in using independent decision-making skills and sound judgment to positively impact company success. Dedicated to applying training, monitoring and morale-building abilities to enhance employee engagement and boost performance.

Collaborative leader partners with coworkers to promote engaged, empowering work culture. Documented strengths in building and maintaining relationships with diverse range of stakeholders in dynamic, fast-paced settings.

Innovative and goal-oriented Management professional committed to [Area of expertise]. Dedicated team player skilled at mediation and conflict resolution. Drives company growth through [Action].

Proficient [Job Title] delivering encouragement and feedback to help employees be successful. Energetic professional with great poise. Well-trained in [Skill].

Dedicated [Industry] professional with a history of meeting company goals utilizing consistent and organized practices. Skilled in working under pressure and adapting to new situations and challenges to best enhance the organizational brand.

• Phase I Advanced Pancreatic Cancer [CRA]
• Solid Tumors [CRA, LCRA, PM]
• Multiple Myeloma [PM]
• NSCLC [PM]
• Glioblastoma and Glioma [PM]
• Ovarian – Advanced, recurrent, platinum-resistant [CRA, LCRA, PM]
• Hormone Insufficient Male Hot Flashes [CRA]
• QTc (thorough ECG) trial [PM]
• Phase I (Specialty) First in Human – Oncology [CRA, PM]
• Bioequivalence [PM]
• Phase II/III Non-muscle Invasive Bladder Cancer [PM]
• Parkinson’s Disease [PM]
• Superficial Bladder Cancer [CRA]
• Advanced Urinary Tract Cancer [CRA/LCRA]
• Pancreatic Cancer [CRA, LCRA]
• Intracerebral Hemorrhagic Stroke [CRA]
• Rheumatoid Arthritis [LCRA]
• Type 2 Diabetes Mellitus [LCRA]
• Phase IV Hepatitis C [CRA, LCRA]

• Early Phase Oncology
• Immuno-Oncology
• Monoclonal Antibodies
• First in Human Trials
• Solid Tumors
• Checkpoint Inhibitors
• Basket Trials
• Antibody Drug Candidates (ADCs)
• Adaptive Design Protocols
• Chimeric Antigen Receptors (CAR-T)

• EDCs INFORM RAVE
• IBM/MERGE/eCOS DataTrial (NowEDC)
• ETMFs Veeva Vault TransPerfect (Trial Interactive)